Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection
Four promoters, Cp, Wp, Fp and Qp, are known to participate in transcription of the Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) gene in EBV-infected cell lines. The promoters are used differentially during the different phases of infection and establishment of the stages of latency. This has raised questions about the regulation of the promoters and the molecular mechanisms underlying the switches between them. To obtain a measure of the activity of the different EBNA1 transcription units in EBV-transformed cell lines of different phenotypes, RNA probes were constructed that allowed the detection and relative quantification, by RNase protection analysis, of EBNA1 transcripts initiated at Fp and Qp and, in an indirect manner, Cp/Wp. RNase protection and PCR assays were performed with cytoplasmic RNA from B-lymphoid cell lines in latency stages I, II-III and III and after induction of the virus lytic cycle. The experiments demonstrated that, in addition to previously identified EBNA1 transcripts, cell lines of all latency types also contained different mRNAs that carried sequences from the EBNA1-encoding K exon. Induction of the virus lytic cycle resulted in low levels of an FpQ/U/K-spliced transcript. However, there was a large increase of FpQ- and FpQ/U-spliced transcripts with unknown 3′ sequences. Furthermore, a new transcript, initiated at an unidentified site 5′ of the BamHI f/K cleavage site and continuing through BamHI K into the EBNA1-encoding K exon without interruption, was produced in substantial amounts in the lytic cycle.
AltiokE.,
MinarovitsJ.,
HuL. F.,
Contreras-BrodinB.,
KleinG.,
ErnbergI.1992; Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein–Barr virus nuclear antigens 2–6. Proceedings of the National Academy of Sciences, USA 89:905–909
BodescotM.,
PerricaudetM.,
FarrellP. J.1987; A promoter for the highly spliced EBNA family of RNAs of Epstein–Barr virus. Journal of Virology 61:3424–3430
FavaloroJ.,
TreismanR.,
KamenR.1980; Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping. Methods in Enzymology 65:718–749
HudewentzJ.,
BornkammG. W.,
zur HausenH.1980; Effect of the diterpene ester TPA on Epstein–Barr virus antigen- and DNA synthesis in producer and nonproducer cell lines. Virology 100:175–178
HudsonG. S.,
FarrellP. J.,
BarrellB. G.1985; Two related but differentially expressed potential membrane proteins encoded by the Eco RI Dhet region of Epstein–Barr virus B95-8. Journal of Virology 53:528–535
JanssonA.,
MasucciM.,
RymoL.1992; Methylation of discrete sites within the enhancer region regulates the activity of the Epstein–Barr virus Bam HI W promoter in Burkitt lymphoma lines. Journal of Virology 66:62–69
KerrB. M.,
LearA. L.,
RoweM.,
Croom-CarterD.,
YoungL. S.,
RookesS. M.,
GallimoreP. H.,
RickinsonA. B.1992; Three transcriptionally distinct forms of Epstein–Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Virology 187:189–201
KieffE.1996; Epstein–Barr virus and its replication. In Fields Virology 3rd edn, pp 2343–2396 Edited by
FieldsB. N.,
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott–Raven;
LearA. L.,
RoweM.,
KurillaM. G.,
LeeS.,
HendersonS.,
KieffE.,
RickinsonA. B.1992; The Epstein–Barr virus (EBV) nuclear antigen 1 Bam HI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. Journal of Virology 66:7461–7468
MasucciM. G.,
Contreras-SalazarB.,
RagnarE.,
FalkK.,
MinarovitsJ.,
ErnbergI.,
KleinG.1989; 5-Azacytidine up regulates the expression of Epstein–Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt’s lymphoma line Rael. Journal of Virology 63:3135–3141
MellinghoffI.,
DaibataM.,
HumphreysR. E.,
MulderC.,
TakadaK.,
SairenjiT.1991; Early events in Epstein–Barr virus genome expression after activation: regulation by second messengers of B cell activation. Virology 185:922–928
NilssonT.,
SjöblomA.,
MasucciM. G.,
RymoL.1993; Viral and cellular factors influence the activity of the Epstein–Barr virus BCR2 and BWR1 promoters in cells of different phenotype. Virology 193:774–785
RickstenA.,
OlssonA.,
AnderssonT.,
RymoL.1988; The 5′flanking region of the gene for the Epstein–Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells. Nucleic Acids Research 16:8391–8410
RoweM.,
LearA. L.,
Croom-CarterD.,
DaviesA. H.,
RickinsonA. B.1992; Three pathways of Epstein–Barr virus gene activation from EBNA1-positive latency in B lymphocytes. Journal of Virology 66:122–131
SampleJ.,
BrooksL.,
SampleC.,
YoungL.,
RoweM.,
GregoryC.,
RickinsonA.,
KieffE.1991; Restricted Epstein–Barr virus protein expression in Burkitt lymphoma is due to a different Epstein–Barr nuclear antigen 1 transcriptional initiation site. Proceedings of the National Academy of Sciences, USA 88:6343–6347
SangerF.,
NicklenS.,
CoulsonA. R.1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, USA 74:5463–5467
SchaeferB. C.,
WoisetschlaegerM.,
StromingerJ. L.,
SpeckS. H.1991; Exclusive expression of Epstein–Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proceedings of the National Academy of Sciences, USA 88:6550–6554
SchaeferB. C.,
StromingerJ. L.,
SpeckS. H.1995a; TheEpstein–Barr virus Bam HI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt’s lymphoma cell lines. Journal of Virology 69:5039–5047
SchaeferB. C.,
StromingerJ. L.,
SpeckS. H.1995b; Redefining the Epsteinp-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proceedings of the National Academy of Sciences, USA 92:10565–10569
SpeckS. H.,
StromingerJ. L.1985; Analysis of the transcript encoding the latent Epstein–Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons. Proceedings of the National Academy of Sciences, USA 82:8305–8309
TsaiC. N.,
LiuS. T.,
ChangY. S.1995; Identification of a novel promoter located within the Bam HI Q region of the Epstein–Barr virus genome for the EBNA 1 gene. DNA and Cell Biology 14:767–776
WeigelR.,
FischerD. K.,
HestonL.,
MillerG.1985; Constitutive expression of Epstein–Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein–Barr virus replication. Journal of Virology 53:254–259
Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection